Clinical Trial: Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
Clinical Trial: Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive LeukemiaSponsor and Collaborators
Therapeutic Advances in Childhood Leukemia Consortium
Genzyme
Contact
Contact: Jeannette M van der Giessen
323-361-8725
jvandergiessen@chla.usc.edu
Contact: Elena Eckroth
323-361-5429
eeckroth@chla.usc.edu
Principal Investigator
Blythe Thomson, MD Seattle Children's Hospital
ClinicalTrials.gov Identifier
NCT01158885
